Translate this page to:
In JoVE (1)
- Orthotope Aorta Transplantatie: Een Rat Model voor de ontwikkeling van chronische vasculopathie Study
Other Publications (1)
This translation into Dutch was automatically generated.
English Version | Other Languages
Articles by Mandy Stubbendorff in JoVE
Orthotope Aorta Transplantatie: Een Rat Model voor de ontwikkeling van chronische vasculopathie Study
Mandy Stubbendorff1, Tobias Deuse1,2, Anna Hammel1, Robert C. Robbins2, Hermann Reichenspurner1, Sonja Schrepfer1,2
1University Heart Center Hamburg, Transplant and Stem Cell Immunobiology Lab (TSI), University Hospital Hamburg, 2Stanford University School of Medicine
Deze video toont de orthotope aorta transplantatie model als een eenvoudig model om de ontwikkeling van transplantatie vasculopathie (TVP) studie bij ratten.
Other articles by Mandy Stubbendorff on PubMed
Cell Transplantation. 2011 | Pubmed ID: 21054940
We here present an immunologic head-to-head comparison between human umbilical cord lining mesenchymal stem cells (clMSCs) and adult bone marrow MSCs (bmMSCs) from patients >65 years of age. clMSCs had significantly lower HLA class I expression, higher production of tolerogenic TGF-β and IL-10, and showed significantly faster proliferation. In vitro activation of allogeneic lymphocytes and xenogeneic in vivo immune activation was significantly stronger with bmMSCs, whereas immune recognition of clMSCs was significantly weaker. Thus, bmMSCs were more quickly rejected in immunocompetent mice. IFN-γ at 25 ng/ml increased both immunogenicity by upregulation of HLA class I/ HLA-DR expression and tolerogenicity by increasing intracellular HLA-G and surface HLA-E expression, augmenting TGF-β and IL-10 release, and inducing indoleamine 2,3-dioxygenase (IDO) expression. Higher concentrations of IFN-γ (>50 ng/ml) further enhanced the immunosuppressive phenotype of clMSCs, more strongly downregulating HLA-DR expression and further increasing IDO production (at 500 ng/ml). The net functional immunosuppressive efficacy of MSCs was tested in mixed lymphocyte cultures. Although both clMSCs and bmMSCs significantly reduced in vitro immune activation, clMSCs were significantly more effective than bmMSCs. The veto function of both MSC lines was enhanced in escalating IFN-γ environments. In conclusion, clMSCs show a more beneficial immunogeneic profile and stronger overall immunosuppressive potential than aged bmMSCs.